|
Name |
Aspernolide A
|
| Molecular Formula | C24H24O7 | |
| IUPAC Name* |
methyl (2R)-2-[(2,2-dimethyl-3,4-dihydrochromen-6-yl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
|
|
| SMILES |
CC1(CCC2=C(O1)C=CC(=C2)C[C@@]3(C(=C(C(=O)O3)O)C4=CC=C(C=C4)O)C(=O)OC)C
|
|
| InChI |
InChI=1S/C24H24O7/c1-23(2)11-10-16-12-14(4-9-18(16)30-23)13-24(22(28)29-3)19(20(26)21(27)31-24)15-5-7-17(25)8-6-15/h4-9,12,25-26H,10-11,13H2,1-3H3/t24-/m1/s1
|
|
| InChIKey |
YCHNFUWRXHTAFK-XMMPIXPASA-N
|
|
| Synonyms |
Aspernolide A; CHEMBL4068225; BDBM50453563; methyl (2R)-2-[(2,2-dimethyl-3,4-dihydrochromen-6-yl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate; methyl (2R)-2-[(2,2-dimethylchroman-6-yl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxo-furan-2-carboxylate
|
|
| CAS | NA | |
| PubChem CID | 25265784 | |
| ChEMBL ID | CHEMBL4068225 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 424.4 | ALogp: | 3.8 |
| HBD: | 2 | HBA: | 7 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 102.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 31 | QED Weighted: | 0.709 |
| Caco-2 Permeability: | -4.964 | MDCK Permeability: | 0.00002180 |
| Pgp-inhibitor: | 0.962 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.513 |
| 30% Bioavailability (F30%): | 0.883 |
| Blood-Brain-Barrier Penetration (BBB): | 0.037 | Plasma Protein Binding (PPB): | 98.36% |
| Volume Distribution (VD): | 0.369 | Fu: | 1.15% |
| CYP1A2-inhibitor: | 0.221 | CYP1A2-substrate: | 0.801 |
| CYP2C19-inhibitor: | 0.908 | CYP2C19-substrate: | 0.415 |
| CYP2C9-inhibitor: | 0.937 | CYP2C9-substrate: | 0.916 |
| CYP2D6-inhibitor: | 0.57 | CYP2D6-substrate: | 0.73 |
| CYP3A4-inhibitor: | 0.94 | CYP3A4-substrate: | 0.629 |
| Clearance (CL): | 10.662 | Half-life (T1/2): | 0.148 |
| hERG Blockers: | 0.054 | Human Hepatotoxicity (H-HT): | 0.645 |
| Drug-inuced Liver Injury (DILI): | 0.639 | AMES Toxicity: | 0.19 |
| Rat Oral Acute Toxicity: | 0.51 | Maximum Recommended Daily Dose: | 0.623 |
| Skin Sensitization: | 0.048 | Carcinogencity: | 0.534 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
| Respiratory Toxicity: | 0.024 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002900 | ![]() |
0.794 | D06TJJ | ![]() |
0.306 | ||
| ENC003498 | ![]() |
0.686 | D0Q9ON | ![]() |
0.280 | ||
| ENC002376 | ![]() |
0.680 | D01XBA | ![]() |
0.276 | ||
| ENC003721 | ![]() |
0.646 | D0JY8T | ![]() |
0.270 | ||
| ENC002571 | ![]() |
0.629 | D0J7RK | ![]() |
0.265 | ||
| ENC000875 | ![]() |
0.629 | D06XZW | ![]() |
0.265 | ||
| ENC002729 | ![]() |
0.629 | D04UTT | ![]() |
0.262 | ||
| ENC002552 | ![]() |
0.617 | D06HBQ | ![]() |
0.260 | ||
| ENC002705 | ![]() |
0.606 | D08CCE | ![]() |
0.259 | ||
| ENC002711 | ![]() |
0.606 | D0Y2NE | ![]() |
0.257 | ||